Ruxolinitib As Salvage Therapy for Chronic Graft-Versus-Host Disease

被引：0
|
作者：
Modi, Badri
Hernandez-Henderson, Michael
Kopp, Erin
Yang, Dongyun
Huelsman, Karen
Sollena, Pietro
Zain, Jasmine M.
Ali, Haris
Al Malki, Monzr M.
Spielberger, Ricardo
Dadwal, Sanjeet
Salhotra, Amandeep
Forman, Stephen J.
Parker, Pablo
Nakamura, Ryotaro
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1976
引用
收藏
页数：2
相关论文
共 50 条
  • [1] THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
    PARKER, PM
    CHAO, N
    NADEMANEE, A
    ODONNELL, MR
    SCHMIDT, GM
    SNYDER, DS
    STEIN, AS
    SMITH, EP
    MOLINA, A
    STEPAN, DE
    KASHYAP, A
    PLANAS, I
    SPIELBERGER, R
    SOMLO, G
    MARGOLIN, K
    ZWINGENBERGER, K
    WILSMAN, K
    NEGRIN, RS
    LONG, GD
    NILAND, JC
    BLUME, KG
    FORMAN, SJ
    BLOOD, 1995, 86 (09) : 3604 - 3609
  • [2] Etanercept as salvage therapy for chronic graft-versus-host disease
    Gulbis, A. M.
    Hsu, Y.
    Neumann, J. L.
    Hymes, S.
    de Lima, M. J.
    Hosing, C. M.
    Khouri, I. F.
    Qazilbash, M. H.
    Kebriaei, P.
    Andersson, B. S.
    Champlin, R. E.
    Couriel, D. P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 107 - 108
  • [3] Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease
    Modi, Badri
    Hernandez-Henderson, Michael
    Yang, Dongyun
    Klein, Jeremy
    Dadwal, Sanjeet
    Kopp, Erin
    Huelsman, Karen
    Mokhtari, Sally
    Ali, Haris
    Al Malki, Monzr M.
    Spielberger, Ricardo
    Salhotra, Amandeep
    Parker, Pablo
    Forman, Stephen
    Nakamura, Ryotaro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (02) : 265 - 269
  • [4] Rituximab as salvage therapy for refractory chronic graft-versus-host disease
    Mohty, M.
    Marchetti, N.
    El-Cheikh, J.
    Faucher, C.
    Fuerst, S.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S231 - S231
  • [5] Rapamycine (Sirolimus) as salvage therapy for chronic graft-versus-host disease
    Jurado, M
    Vallejo, C
    Pérez-Simón, J
    Brunet, S
    Balsalobre, P
    Pérez-Oteyza, J
    Espigado, I
    Romero, A
    Caballero, D
    Díez, J
    Vázquez, L
    BONE MARROW TRANSPLANTATION, 2005, 35 : S139 - S139
  • [6] Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis
    Fante, M. A.
    Wertheimer, T.
    Holler, B.
    Kattner, A. -S.
    Martinovic, D.
    Hoepting, M.
    Weber, D.
    Edinger, M.
    Holler, E.
    Herr, W.
    Wolff, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 284 - 285
  • [7] Rituximab as salvage therapy for refractory sclerodermatous chronic graft-versus-host disease
    Namdaroglu, S.
    Iskender, D.
    Dal, M. S.
    Cakar, M. K.
    Tekgunduz, E.
    Altuntas, F.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2019, 27 (01): : 12 - 18
  • [8] Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis
    Tobias Wertheimer
    Marius Dohse
    Gabriel Afram
    Daniela Weber
    Martin Heidenreich
    Barbara Holler
    Anna-Sophia Kattner
    Andreas Neubauer
    Stephan Mielke
    Per Ljungman
    Ernst Holler
    Wolfgang Herr
    Matthias Edinger
    Antonio Pérez Martínez
    Matthias Fante
    Daniel Wolff
    Annals of Hematology, 2021, 100 : 779 - 787
  • [9] Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis
    Fante, Matthias A.
    Holler, Barbara
    Weber, Daniela
    Angstwurm, Klemens
    Bergler, Tobias
    Holler, Ernst
    Edinger, Matthias
    Herr, Wolfgang
    Wertheimer, Tobias
    Wolff, Daniel
    ANNALS OF HEMATOLOGY, 2020, 99 (09) : 2181 - 2190
  • [10] Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis
    Matthias A. Fante
    Barbara Holler
    Daniela Weber
    Klemens Angstwurm
    Tobias Bergler
    Ernst Holler
    Matthias Edinger
    Wolfgang Herr
    Tobias Wertheimer
    Daniel Wolff
    Annals of Hematology, 2020, 99 : 2181 - 2190
12345